AAAAAA

   
Results: 1-13 |
Results: 13
CLONING, SEQUENCING AND STRUCTURAL-ANALYSIS OF 976 BASE-PAIRS OF THE PROMOTER SEQUENCE FOR THE RAT LIPOPROTEIN-LIPASE GENE - COMPARISON WITH THE MOUSE AND HUMAN SEQUENCES
Authors: BEY L ETIENNE J TSE C BRAULT D NOE L RAISONNIER A ARNAULT F HAMILTON MT GALIBERT F
Citation: L. Bey et al., CLONING, SEQUENCING AND STRUCTURAL-ANALYSIS OF 976 BASE-PAIRS OF THE PROMOTER SEQUENCE FOR THE RAT LIPOPROTEIN-LIPASE GENE - COMPARISON WITH THE MOUSE AND HUMAN SEQUENCES, Gene, 209(1-2), 1998, pp. 31-38
PHARMACOKINETIC PROFILE OF THE INDUCTION DOSE OF PROPOFOL IN PATIENTSWITH SEVERE BURNS
Authors: DEGASPERI A NOE L PROSPERI M AMICI O NOTARO P HEINEN M ROMANO P SANTANDREA E
Citation: A. Degasperi et al., PHARMACOKINETIC PROFILE OF THE INDUCTION DOSE OF PROPOFOL IN PATIENTSWITH SEVERE BURNS, Clinical drug investigation, 14(4), 1997, pp. 314-320
SEQUENCE OF THE RAT PROMOTER LIPOPROTEIN-LIPASE GENE
Authors: BEY L BRAULT D NOE L ARNAULT F TSE C RAISONNIER A HAMILTON MT ETIENNE J
Citation: L. Bey et al., SEQUENCE OF THE RAT PROMOTER LIPOPROTEIN-LIPASE GENE, Atherosclerosis, 134(1-2), 1997, pp. 22-22
ANTIMICROBIAL PEPTIDES FROM MIRABILIS-JALAPA AND AMARANTHUS-CAUDATUS - EXPRESSION, PROCESSING, LOCALIZATION AND BIOLOGICAL-ACTIVITY IN TRANSGENIC TOBACCO
Authors: DEBOLLE MFC OSBORN RW GODERIS IJ NOE L ACLAND D HART CA TORREKENS S VANLEUVEN F BROEKAERT WF
Citation: Mfc. Debolle et al., ANTIMICROBIAL PEPTIDES FROM MIRABILIS-JALAPA AND AMARANTHUS-CAUDATUS - EXPRESSION, PROCESSING, LOCALIZATION AND BIOLOGICAL-ACTIVITY IN TRANSGENIC TOBACCO, Plant molecular biology, 31(5), 1996, pp. 993-1008
USE OF PREDICTED RISK OF MORTALITY TO EVALUATE THE EFFICACY OF ANTICYTOKINE THERAPY IN SEPSIS
Authors: KNAUS WA HARRELL FE LABRECQUE JF WAGNER DP PRIBBLE JP DRAPER EA FISHER CJ SOLL L ASTIZ M RACKOW EC CARPATI C BALK RA FRIEDMAN B MURE AJ SHAPIRO E MELHOM L SHAPIRO MJ TAYLOR R KEEGAN M OBRIEN J GREENMAN RL SCHEIN R PENA M WASSERLOUF M IBERTI TJ OROPELLO J BENJAMIN E DELGUIDICE R EMMANUEL G LIE T ANDERSON L MARSHALL J DEMAJO W ROTSTEIN O FOSTER D ABRAHAM E MIDDLETON H PERRY C LEVY H FRY DE SIMPSON SQ CROWELL RE NEIDHART M STEVENS D COFFMAN T NARASIMHAN N MERRICK DK BERQUIST W MATZEL K HUEBLER M FOULKE G ALBERTSON T WALBY W ALLEN R BAUGHMAN R HASSELGREN PO FINK MP FAVORITO F THOMAS BT CORBIN R SHELLHORSE GY FRAZIER A WHITE S GARRARD C ACOURT C GERVICH D BRASE R BAGDAHN A COONEY R SMITH JS VINCENT JL FRIEDMAN G BERLOT G FLETCHER JR WILLIAMS MD WRIGHT TF JOHNSON S FEILD C WOLF K MACINTYRE N DUBIN H DURKIN M STAUBACH KH FEIN AM SCHULMAN DB NIEDERMAN MS CHALFIN DB VANLEEUVEN PAM BANDER J IMM A BERNARD G NELSON L STROUD M SAFCSAK K CERRA F RINDAL J MANN H HALPERN N ALICEA M SIBBALD WJ MARTIN CM RUTLEDGE FS PETTI K RUSSELL J KRUGER R DRUMMOND A FISHER CS LANGE P SELFERT T DUROCHER A TENAILLON A BOITEAU R LHERM T LOWRY S COYLE SM BARIE PS DEMARIA E REINES HD SNYDMAN D SCHWAITZBERG S NASRAWAY S GRINDLINGER J SUMMER W DEBOISBLANC B WAHL M ALESTIG K GROSSMAN J MAKI D PAZ HL WEINER M BIHARI D BLEICHNER G DAHN M HALL J WENZEL RP GROSSERODE M COSTIGAN M MILESKI W WEIGELT J YESTON N IRIZARRY C ROSS J ROBBINS J SHELLY MP NIGHTINGALE P OWEN K SANDSTEDT S BERG S SIMON G SENEFF M CONRY K ZIMMERMAN JL DELLINGER RP JOHNSTON R ALLEE P GRANDE PO MYHRE E DHAINAUT JF HAMY I MIRA JP HARMON J WHITE J MCKIE L SILVERMAN H TUMA P BENNETT D LAURELL MH JACOBS S ASH S OPAL SM SLOTMAN GJ IBERTI TJ SADOFF JC STILES DM THOMPSON B PRIOR MJ KNATTERUD G TERRIN M KUFERA J WILKENS P RA K MONROE L SPRUNG C HAMILTON CM MATTHAY R MCCABE W TONASCIA J WIEDMAN H WITTES J THOMPSON BW LABRECQUE JF CATALANO MA CAMPION GV CROFT CR LUSTICK R LOOKABAUGH J GORDON GS NOE L BLOEDOW D SMITH CG BRANNON D KUSH R NG D MOORE E BAZEMORE K GALVAN M WAGNER D HARRELL F STABLEIN D
Citation: Wa. Knaus et al., USE OF PREDICTED RISK OF MORTALITY TO EVALUATE THE EFFICACY OF ANTICYTOKINE THERAPY IN SEPSIS, Critical care medicine, 24(1), 1996, pp. 46-56
HUMAN LIPOPROTEIN-LIPASE LAST EXON IS NOT TRANSLATED, IN CONTRAST TO LOWER-VERTEBRATES
Authors: ARNAULT F ETIENNE J NOE L RAISONNIER A BRAULT D HARNEY JW BERRY MJ TSE C FROMENTALRAMAIN C HAMELIN J GALIBERT F
Citation: F. Arnault et al., HUMAN LIPOPROTEIN-LIPASE LAST EXON IS NOT TRANSLATED, IN CONTRAST TO LOWER-VERTEBRATES, Journal of molecular evolution, 43(2), 1996, pp. 109-115
THE TREATMENT OF RHEUMATOID-ARTHRITIS (RA) IN MANAGED CARE - A PHARMACOECONOMIC ASSESSMENT
Authors: NOE L HEATON A SCHNEIDER BB BRYANT J SIMONS R HAIM M TROTTER J
Citation: L. Noe et al., THE TREATMENT OF RHEUMATOID-ARTHRITIS (RA) IN MANAGED CARE - A PHARMACOECONOMIC ASSESSMENT, Arthritis and rheumatism, 39(9), 1996, pp. 272-272
COMPARISON OF THE CDNA AND AMINO-ACID-SEQUENCES OF LIPOPROTEIN-LIPASEIN 8 SPECIES
Authors: RAISONNIER A ETIENNE J ARNAULT F BRAULT D NOE L CHUAT JC GALIBERT F
Citation: A. Raisonnier et al., COMPARISON OF THE CDNA AND AMINO-ACID-SEQUENCES OF LIPOPROTEIN-LIPASEIN 8 SPECIES, Comparative biochemistry and physiology. B. Comparative biochemistry, 111(3), 1995, pp. 385-398
HOMOZYGOUS DELETION OF EXON-9 CAUSES LIPOPROTEIN-LIPASE DEFICIENCY - POSSIBLE INTRON-ALU RECOMBINATION
Authors: BENLIAN P ETIENNE J DEGENNES JL NOE L BRAULT D RAISONNIER A ARNAULT F HAMELIN J FOUBERT L CHUAT JC TSE CT GALIBERT F
Citation: P. Benlian et al., HOMOZYGOUS DELETION OF EXON-9 CAUSES LIPOPROTEIN-LIPASE DEFICIENCY - POSSIBLE INTRON-ALU RECOMBINATION, Journal of lipid research, 36(2), 1995, pp. 356-366
OPTIMAL VENTILATION IN LAPAROSCOPIC SURGERY OF GALLBLADDER
Authors: FERNANDEZ D FONTANA F NOE L MORAL V
Citation: D. Fernandez et al., OPTIMAL VENTILATION IN LAPAROSCOPIC SURGERY OF GALLBLADDER, British Journal of Anaesthesia, 74, 1995, pp. 52-52
FENTANYL PRETREATMENT DOES NOT AFFECT THE PHARMACOKINETIC PROFILE OF AN INDUCTION DOSE OF PROPOFOL IN ADULTS
Authors: DEGASPERI A CRISTALLI A NOE L SABBADINI D MAZZA E PROSPERI M FANTINI G CRESPI AM REZZANI S
Citation: A. Degasperi et al., FENTANYL PRETREATMENT DOES NOT AFFECT THE PHARMACOKINETIC PROFILE OF AN INDUCTION DOSE OF PROPOFOL IN ADULTS, European journal of anaesthesiology, 11(2), 1994, pp. 89-93
RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: FISHER CJ DHAINAUT JFA OPAL SM PRIBBLE JP BALK RA SLOTMAN GJ IBERTI TJ RACKOW EC SHAPIRO MJ GREENMAN RL REINES HD SHELLY MP THOMPSON BW LABRECQUE JF CATALANO MA KNAUS WA SADOFF JC ASTIZ M CARPATI C BONE RC FREIDMAN B MURE AJ BRATHWAITE C SHAPIRO E MELHORN L TAYLOR R KEEGAN M OBRIEN J SCHEIN R PENA M WASSERLOUF M OROPELLO J BENJAMIN E DELGUIDICE R EMMANUEL G LIE T ANDERSON L MARSHALL J DEMAJO W ROTSTEIN O FOSTER D ABRAHAM E MIDDLETON H PERRY C LEVY H FRY DE SIMPSON SQ CROWELL RE NEIDHART M STEVENS D COFFMAN T NARASIMHAM N MERRICK DK BERGQUIST W MATZEL KE HUEBLER M FOULKE GE ALBERTSON TE WALBY WF ALLEN RP BAUGHMAN R HASSELGREN PO FINK MP FAVORITO F THOMPSON BT CORBIN R SHELLHORSE GY FRAZIER A WHITE S GARRARD C ACOURT C STORER S GERVICH DH FOSHE D BRASE R BAGDAHN A COONEY R SMITH JS MARTIN LF VINCENT JL FRIEDMAN G BERLOT G FLETCHER JR WILLIAMS MD WRIGHT TF JOHNSON S FEILD C WOLF K MACINTYRE N DUBIN HG DURKIN MR DUBIN PK STAUBACH KH FEIN AM SCHULMAN DB NIEDERMAN MS CHALFIN DB VANLEEUWEN PAM BOERMEESTER MA SCHNEIDER AJ BANDER J IMM A BERNARD G NELSON L STROUD M SAFCSAK K CERRA F RINDAL J MANN H HALPERN N SILVERSTEIN J ALICEA M SIBBALD WJ MARTIN CM RUTLEDGE FS PETTI K RUSSELL JA KRUGER R DRUMMOND A LANGE P SEIFERT T DUROCHER A TENAILLON A BOITEAU R LHERM T LOWRY SF COYLE SM BARIE PS DEMARIA E SNYDMAN DR SCHWAITZBERG SD NASRAWAY SA GRINDLINGER J SUMMER W DEBOISBLANC B WAHL M ALESTIG K GROSSMAN J MAKI D PAZ HL WEINER M BIHARI D CAMPBELL D BLEICHNER G DAHN MS LANGE MPA HALL J POHLMAN A WENZEL RP GROSSERODE M COSTIGAN M MILESKI W WEIGELT J YESTON N IRIZARRY C ROSS J ROBBINS J NIGHTINGALE P OWEN K SANDSTEDT S BERG S SIMON GL SENEFF MG CONRY KM ZIMMERMAN JL DELLINGER RP JOHNSTON R ALLEE P GRANDE PO MYHRE E DHAINAUT JF HAMY I MIRA JP HARMON J WHITE J MCKIE L SILVERMAN H TUMA P BENNETT D PORTER JC LAURELL MH JACOBS S ASH S STILES DM PRIOR MJ KNATTERUD G TERRIN M KUFERA J WILKENS P RA K MONROE L SPRUNG C HAMILTON CM MATTHAY R MCCABE W TONASCIA J WIEDEMAN H WITTES J CAMPION GV CROFT CR LUSTICK R LOOKABAUGH J GORDON GS NOE L BLOEDOW D SMITH CG BRANNON D KUSH R NG D MOORE E BAZEMORE K GALVAN M WAGNER D HARRELL F STABLEIN D
Citation: Cj. Fisher et al., RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 271(23), 1994, pp. 1836-1843
GENES OF LIPASE SUPERFAMILY - COMPARISON OF NUCLEIC AND PROTEINIC SEQUENCES
Authors: RAISONNIER A BRAULT D NOE L ETIENNE J HAMELIN J CHUAT JC DUGAIL I QUIGNARDBOULANGE A LAVAU M GALIBERT F
Citation: A. Raisonnier et al., GENES OF LIPASE SUPERFAMILY - COMPARISON OF NUCLEIC AND PROTEINIC SEQUENCES, Comptes rendus des seances de la Societe de biologie et de ses filiales, 186(6), 1992, pp. 666-681
Risultati: 1-13 |